NASDAQ:NMTC | Free Cash Flow | NEUROONE MEDICAL TECHNOLOGIES Corp

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$3.12M$40,754.00-$3.16M
2025-09-30-$1.53M$10,607.00-$1.54M
2024-12-31$208,049.00$24,416.00$183,633.0010.29%
2024-09-30-$2.67M$36,905.00-$2.7M
2023-12-31-$3.81M$37,131.00-$3.85M
2023-09-30-$2.9M$57,620.00-$2.96M
2022-12-31-$3.49M$11,512.00-$3.5M
2022-09-30$1.02M$66,182.00$951,635.00
2021-12-31-$2.68M$61,491.00-$2.74M
2021-09-30-$2.03M$35,109.00-$2.06M
2020-12-31-$1.9M
2020-09-30$272,668.00$56,359.00$216,309.00
2019-12-31-$1.22M$10,271.00-$1.24M
2019-09-30-$1.14M-$60,600.00-$1.2M
2018-12-31-$699,684.00
2018-03-31-$591,269.00
2017-12-31-$598,404.00
2017-03-31-$350,919.00
2016-12-31-$7,329.00
2016-03-31$0.00
2015-12-31-$6,353.00
2015-03-31-$19,591.00
2014-12-31-$9,029.00
2014-03-31-$25.00
2013-12-31-$2,583.00
2013-03-31-$2,985.00
2012-12-31-$1,367.00
2012-03-31-$5,519.00
2011-12-31-$15,458.00
2011-03-31-$6,662.00
2010-12-31-$547.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$2.84M$81,742.00-$2.92M
2024-09-30-$11.01M$120,197.00-$11.13M
2023-09-30-$12.89M$384,117.00-$13.27M
2022-09-30-$7.52M$275,226.00-$7.79M
2021-09-30-$8.6M$67,079.00-$8.67M
2020-09-30-$3.43M$122,427.00-$3.55M
2019-09-30-$5.4M$58,352.00-$5.45M
2016-12-31-$21,106.00
2015-12-31-$30,229.00
2014-12-31-$26,173.00
2013-12-31-$25,093.00
2012-12-31-$13,733.00
2011-12-31-$27,428.00
2010-12-31-$5,092.00